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Post-exercise skeletal muscle
glycogen related to plasma cytokines
and muscle IL-6 protein content, but
not muscle cytokine mRNA
expression
David C. Nieman1*, Kevin A. Zwetsloot1, Mary Pat Meaney 1, Dominic D. Lomiwes2,
Suzanne M. Hurst2 and Roger D. Hurst2
1 Appalachian State University, Kannapolis, NC, USA, 2 The New Zealand Institute for Plant and Food Research Ltd., Palmerston
North, New Zealand
Objectives: The purpose of this study was to correlate post-exercise muscle glycogen
levels with changes in plasma cytokine, and muscle mRNA cytokine expression and
protein content.
Methods: Twenty-four male runners (age 36.51.8 years, VO2max 60.0
1.5mLkg 1 min 1) ran twice (separated by 4weeks) on treadmills to exhaustion
at 70% VO2max (average time and distance of 2.240.09 h and 24.91.1 km). Muscle
biopsies from the vastus lateralis and blood samples were collected before and after
each run, with IL-6, IL-8, and MCP-1 measured in muscle (mRNA and protein) and
plasma. Data from the two runs were averaged.
Results: Participants experienced a 35.34.2% decrease (P<0.001) in skeletal
muscle glycogen content (67.52.8 to 44.33.7mmolkg 1 wet weight). Muscle
mRNA expression for IL-6, IL-8, and MCP-1 increased 7.340.90-, 13.92.3-, and
4.100.60-fold, respectively (all, P<0.001). Skeletal muscle IL-6, IL-8, and MCP-
1 protein content increased 35.810.6, 80.612.1, and 10517.9%, respectively
(all, P0.005). Plasma IL-6, IL-8, and MCP-1 increased 47.110.0-, 2.60.3-, and
1.60.1-fold, respectively (all, P<0.001). Post-exercise muscle glycogen concentra-
tions were negatively correlated with run time to exhaustion (r= 0.70, P<0.001), and
changes in muscle IL-6 protein content (r= 0.44, P=0.049), plasma IL-6 (r= 0.72,
P<0.001), IL-8 (r= 0.60, P=0.002), and MCP-1 (r= 0.589, P=0.002), but not with
changes in muscle IL-8 and MCP-1 protein content, or muscle mRNA expression for IL-6,
IL-8, and MCP-1.
Conclusion: Prolonged and intensive running increased muscle mRNA expression,
muscle protein content, and plasma levels for IL-6, IL-8, andMCP-1, and post-runmuscle
glycogen levels were most strongly related to plasma cytokine levels.
Keywords: running, interleukin-6, interleukin-8, monocyte chemoattractant protein-1, chemokines
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Introduction
Cytokines are a broad category of small proteins that are important
in cell signaling, act through receptors, and affect the behavior
of other cells. Cytokines are released by a range of immune
cells, endothelial cells, adipocytes, muscle cells, and other cells,
and include chemokines, interferons, interleukins, lymphokines,
and tumor necrosis factor (1–3). Considerable attention has
focused on the potential for regular exercise to counteract a
range of disease states by stimulating cytokine production and
release (2, 3).
The six cytokines with the greatest fold increase in plasma
during prolonged and intensive exercise include IL-6,
IL-10, granulocyte colony stimulating factor (G-CSF), IL-8,
interleukin-1 receptor antagonist (IL-1ra), and monocyte
chemoattract protein-1 (MCP-1) (4–6). These cytokines exert
anti-inflammatory and chemotactic influences, and are produced
by multiple cell types both within and outside the immune
system and skeletal muscle tissue (1, 3, 7). Post-exercise muscle
biopsy samples contain muscle cells that can produce and
release IL-6 and MCP-1, resident macrophages (IL-6, IL-10,
IL-8, MCP-1, and G-CSF), and endothelial/epithelial cells (IL-8,
MCP-1, IL-1ra, and G-CSF) (1, 4, 8–12). Blood monocytes and
lymphocytes can contribute to elevated plasma cytokine levels
following exercise by producing IL-10, IL-1ra, and IL-8 (4).
The acute, large exercise-induced increases in IL-6 and other
cytokines orchestrate anti-inflammatory influences, augment
lipolysis, stimulate chemotaxis, improve insulin sensitivity, serve
as signaling agents for training adaptations and tissue repair, and
function in many other roles related to health (1–3, 8).
The primary signaling mechanisms for inducing cytokine gene
expression and production during intensive exercise are still
being investigated, with a focus on muscle damage and metabolic
demands, including glycogen depletion and total exercise work-
load (1, 8, 9, 11, 13–20). Post-exercise cytokine gene expression
and secretion can be modified by other forms of physiological
stress (e.g., heat, mode of exercise, age) (19, 21–23) medica-
tions (e.g., ibuprofen) (5), and nutritional factors (carbohydrate
availability, high vitamin E intake, free fatty acid availability,
and polyphenol supplementation) (11, 16, 24, 25). Carbohydrate
ingestion before and during intensive and prolonged exercise,
especially in overnight fasted endurance athletes, decreases skele-
tal muscle mRNA expression for IL-6 and IL-8, and lowers post-
exercise plasma levels for IL-6, IL-8, IL-1ra, and IL-10 (11).
In response to published reports that carbohydrate ingestion
during prolonged exercise attenuated the plasma IL-6 response,
Steensberg et al. (26) hypothesized that a link may exist between
lowmuscle glycogen content and IL-6 production during exercise.
Using a two-legged knee-extensor exercise design, IL-6 mRNA
levels and IL-6 release were shown to be augmented in the ~40%
glycogen-depleted leg compared with the control leg in sevenmen
who exercised for 5 h. Keller et al. (27) showed that muscle IL-6
mRNA and transcriptional activity were enhanced when six male
participants engaged in 3 h of two-legged knee-extensor exercise
with low muscle glycogen levels. Chan et al. (13) reported that
exercising (60min cycling, ~70% VO2max) in a glycogen-depleted
state increased muscle IL-6 and IL-8 mRNA expression, with
slightly higher plasma IL-6 but not IL-8 levels. Other studies have
not been able to show that variance in muscle glycogen depletion
with exercise is related to muscle IL-6 or IL-8 mRNA expression
(11, 14, 15). Helge et al. (15) showed that IL-6 release is markedly
higher from the exercising arms than the legs during whole-
body exercise, and is not related to muscle glycogen utilization.
Thus, the role of glycogen availability in the contracting muscle
as a primary signaling mechanism for cytokine mRNA expression
and release into the circulation is unclear, and interpretation has
beenmademore difficult through research designs utilizing small
subject numbers and modest exercise workloads (14–17).
The purpose of this study was to relate post-exercise muscle
glycogen levels withmuscle mRNA IL-6, IL-8, andMCP-1 expres-
sion and protein content, and change in plasma cytokine levels
in 24 male runners who ran twice on treadmills to exhaustion
at ~70% VO2max. Muscle biopsies from the vastus lateralis and
blood samples were collected before and after each run, and data
from the two runswere averaged to strengthen data quality, reduce
random measurement error, and provide better estimates of the
“true” value for individual participants (28).
Materials and Methods
Participants
Subject recruitment was conducted via direct messaging to run-
ners and running clubs in the Charlotte, NC, USA, metropolitan
area. Participants included 24 male runners (ages 27–49 years)
who regularly competed in long-distance road races and were
capable of running at ~70% on treadmills to exhaustion. During
the study, participants consented to train normally, maintain
weight, and avoid the use of large-dose vitamin and mineral sup-
plements (above 100% Daily Value), and all herbal supplements
and medications (in particular, non-steroidal anti-inflammatory
drugs) for the 4-week period separating the two lab sessions.
Participants signed informed consent forms and study procedures
were approved by the Institutional Review Board at Appalachian
State University (ASU).
Baseline Testing
Two weeks prior to the first running trial in the ASU Human Per-
formance Laboratory, participants were tested for VO2max during
a graded, treadmill testwith theCosmedFitmatemetabolic system
(Cosmed, Rome, Italy) (29). Body composition was measured
with the Bod Pod body composition analyzer (Life Measurement,
Concord, CA, USA). Demographic and training histories were
acquired with questionnaires.
Running Trials
During the 3-day period prior to each running trial (separated by
4weeks), participants followed a moderate-carbohydrate dietary
regimen (~55% kcal as carbohydrates) by choosing foods from
a list provided by the investigative team. A standardized meal
consisting of Boost Plus (Néstle Nutrition, Slorham Park, NJ,
USA) was ingested at 12:00 p.m., with energy intake adjusted
to 5 kcalkg 1 body weight. Boost Plus is a nutritionally com-
plete, high-energy oral supplement with an energy density of
6.4 kJmL 1 (1.52 kcalmL 1) and 15% of energy as protein, 35%
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as fat, and 50% as carbohydrate, and 24 vitamins and minerals.
Participants reported to the lab at 2:15 p.m. and provided blood
and muscle biopsy samples. At 3:00 p.m., participants ran on
laboratory treadmills with the speed set at 70% of VO2max, and
drank water ad libitum, without ingestion of any other beverages
or food. Participants ran as long as possible until exhaustion,
defined as the inability of the subject to continue running at 70%
VO2max despite verbal urging from the laboratory staff. Metabolic
measures from the Cosmed Fitmate metabolic system and the
rating of perceived exertion (RPE) were taken at 15min, and then
every 60min during the running bout to verify that the appro-
priate intensity was maintained. Blood and muscle samples were
taken again immediately following exercise. These procedures
were repeated 4weeks later, with runners following the exact same
schedule (including same time and day of the week), and running
at the same treadmill speed to exhaustion.
Cytokine Analysis
Total plasma concentrations of three cytokines [monocyte
chemoattractant protein-1 (MCP-1), IL-6, and IL-8] were deter-
mined using an electrochemiluminescence-based solid-phase
sandwich immunoassay (Meso Scale Discovery, Gaithersburg,
MD, USA). All samples and provided standards were analyzed in
duplicate, and the intra-assay CV ranged from 1.7 to 7.5% and the
inter-assayCV2.4–9.6% for all cytokinesmeasured. Pre- andpost-
exercise samples for the cytokineswere analyzed on the same assay
plate to decrease inter-kit assay variability.
Stress Hormone Analysis
Serum cortisol was measured with an electrochemilumines-
cence immunoassay (ECLIA), and plasma epinephrine with high-
pressure liquid chromatography (HPLC) and electrochemical
(EC) detection through a commercial lab (LabCorp, Burlington,
NC, USA).
Muscle Biopsy Procedures and Glycogen
Analysis
Pre- and post-exercise muscle biopsy samples were acquired from
the vastus lateralis on the same leg ~2 cm apart using procedures
previously described (30). During the second running trial, the
same procedures were followed, but on the opposite leg. Local
anesthesia (1% xylocaine, Hospira, Inc., Lake Forest, IL, USA) was
injected subcutaneously. After a small incision, a muscle biopsy
sample was obtained using the suction-modified percutaneous
needle biopsy procedure (30). Muscle was trimmed of connective
tissue and fat and immediately frozen in liquid nitrogen. Samples
were stored at  80°C until subsequent analysis. A glycogen assay
kit (Catalog #MAK016, Sigma-Aldrich, St. Louis, MO, USA) was
used to determine the concentration of glycogen in vastus lateralis
muscle homogenates. In this coupled enzyme assay, glucoamylase
hydrolyzed glycogen to glucose, and then the glucose was oxidized
to yield a product that reacted with a probe to generate a color
detectable with a microplate reader (Synergy H1 Hybrid Reader,
BioTek Instruments, Inc., Winooski, VT, USA) at 570 nm.
Muscle mRNA Measurements
Total RNA extraction of vastus lateralis biopsies was con-
ducted using an RNeasy® Fibrous Tissue Mini Kit (Qiagen,
Limburg, Netherlands) according to the manufacturer’s instruc-
tions. Frozen muscle biopsies were homogenized in RTL-β-
mercaptoethanol Buffer with a Precellys homogenizer (Bertin
Technologies, Montigny-le-Bretonneux, France). An aliquot of
RNA from all samples were run on 1.5 denaturing agarose
gels stained with ethidium bromide to confirm RNA integrity.
Additionally, RNA quality was further verified spectrophoto-
metrically using the A260/A280 ratio which was determined
using a nanodrop. Reverse transcription of RNA into cDNA
was conducted using a High Capacity cDNA Reverse Tran-
scription Kit (Applied Biosystems, Foster City, CA, USA) as
per manufacturer’s instructions. Reverse transcription was per-
formed using a GeneAmp® PCR System 9700 (Applied Biosys-
tems). cDNA was quantified using a nanodrop and aliquots were
stored at  20°C until Real Time-Polymerase Chain Reaction
(RT-PCR) analysis.
Quantitative RT-PCR analysis of messenger RNA (mRNA)
was conducted under pre-optimized TaqMan Gene Expression
Assays (Applied Biosystems) using gene specific FAM dye-labeled
primers for IL-6 (Cat. No. 4453320), IL-8 (Cat. No. 4369514),
MCP-1 (Cat. No. 4331182), and beta-2-microglobulin (B2M)
(Cat. No. 4351370). Samples and reagents were loaded in a
MicroAmP Fast-Optical 96 Well Reaction Plate and run in qua-
druplicate. Plates were analyzed on a 7500 Fast RT-PCR System
(Applied Biosystems). Relative mRNA levels were determined
using the ΔΔCt calculations with B2M serving as the housekeep-
ing gene (31). Changes in cytokine expression post-exercise were
normalized to pre-exercise levels.
Analysis of Skeletal Muscle Inflammatory
Cytokine Protein Concentrations
Skeletal muscle biopsy samples were analyzed for the inflamma-
tory cytokines IL-6, IL-8, andMCP-1 with a magnetic bead-based
multiplex assay using the MAGPIX instrument and xPONENT®
analysis software (Luminex, Austin, TX, USA). Briefly, ~30mg
of each skeletal muscle tissue biopsy sample was homogenized in
lysis buffer (Millipore, Billerica, MA, USA; #43-040) with AEBSF
protease inhibitor added (Millipore; #101500). Homogenates were
cleared by centrifugation at 14,000 g and the protein concen-
tration of the supernatant was determined using a BCA protein
assay kit (Pierce ThermoFisher, Rockford, IL, USA). Next, 30μg of
muscle protein was added to each well (in duplicate) and the con-
centration of each cytokine was measured using theMILLIPLEX®
MAP assay kit (Millipore, #HCYTOMAG-60K) according to
manufacturer’s specifications. The lower limit of detection and
inter-assay% coefficient of variability (%CV) for this panel of ana-
lytes was: IL-6= 0.17 pgmL 1 (4.2% CV); IL-8= 0.18 pgmL 1
(5.9% CV); and MCP-1= 0.30 pgmL 1 (3.0% CV). The intra-
assay% CVs were IL-6= 13.6%, IL-8= 8.9%, and MCP-1= 3.7%.
Statistical Analysis
Data are expressed as mean SE. Dependent t-tests were used to
test change (pre- to post-exercise), with the level of significance set
at P< 0.01. The Pearson product-moment correlation coefficient
was used as a measure of the linear correlation between two
variables.
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Results
Participants included 24 trained male runners (ages 22–55 years)
who successfully adhered to all aspects of the study design (see
subject characteristics in Table 1). Run distances to exhaustion
and post-exercise muscle glycogen content for the two run tri-
als were significantly correlated (r= 0.74, P< 0.001; r= 0.67,
P< 0.001, respectively), as were between trial post-run plasma
cytokines levels (r= 0.475, 0.545, and 0.584 for plasma IL-
6, IL-8, and MCP-1, respectively, all, P< 0.05). Between trial
correlations for muscle cytokine mRNA and protein levels were
non-significant. Metabolic and performance data from the aver-
age of the two run-to-exhaustion trials are summarized inTable 2.
The runners were able to maintain an average intensity of
69.2 1.3% VO2max for 2.24 0.09 h and 24.8 1.1 km. The RPE
was 17.8 0.2 at the end of the running trials.
Skeletal muscle glycogen sampled from the vastus later-
alis decreased 35.3 4.2% (23.3 2.4mmolkg 1) (P< 0.001),
with post-run values averaging 44.3 3.7mmolkg 1 (range of
7.9–76.7mmolkg 1) (Figure 1).
Muscle mRNA expression for IL-6, IL-8, and MCP-1 increased
7.34 0.90-, 13.9 2.3-, and 4.10 0.60-fold, respectively (all,
P< 0.001) (Figure 2). Skeletal muscle cytokine protein content
increased 35.8 10.6% (P= 0.005) and 80.6 12.1% (P< 0.001)
for IL-6 and IL-8, respectively (Figure 3A), and 105 17.9%
(P< 0.001) for MCP-1 (Figure 3B).
Plasma cytokine and stress hormone data are summarized in
Table 3. Plasma IL-6, IL-8, and MCP-1 increased 47.1 10.0-,
2.6 0.3-, and 1.6 0.1-fold, respectively (all, P< 0.001). Serum
cortisol and plasma epinephrine were elevated post-exercise
99.1 14.42 and 147 18.3%, respectively. No significant corre-
lations were found between pre-to-post changes for each of the
cytokines with changes in serum cortisol and plasma epinephrine
TABLE 1 | Subject characteristics (N=24).
Variable MeanSE
Age (years) 36.51.8
Height (m) 1.780.01
Weight (kg) 77.31.9
Body fat (%) 15.01.0
VO2max (mLkg 1min 1) 60.01.5
HRmax (beatsmin 1) 1852.3
TABLE 2 | Average metabolic and performance data for the two runs to
exhaustion by trained runners.
Variable MeanSE
Time (h) 2.240.09
Distance (km) 24.81.1
VO2 (mLkg 1min 1) 41.30.8
VO2 (% VO2max) 69.21.3
HR (beatsmin 1) 1582.0
% HRmax 85.20.7
Ventilation (L min 1) 77.22.0
RPE 13.90.2
VO2, volume of oxygen consumed; HR, heart rate; RPE, rating of perceived exertion.
(all, P> 0.05). Running distance to exhaustion was significantly
correlated with change in plasma IL-6 (r= 0.503, P= 0.012), IL-8
(r= 0.665, P< 0.001), and MCP-1 (r= 0.735, P< 0.001).
Correlation statistics were calculated for pre-run, post-run,
and absolute change in muscle glycogen with the outcome mea-
sures included in this study, and the strongest correlations (when
significant) were found when using post-run glycogen values.
Significant inverse correlations were measured between post-
run glycogen levels and running time (r= 0.70, P< 0.001) and
distance (r= 0.609, P= 0.002), but not with muscle mRNA
expression for MCP-1 (r= 0.032, P= 0.882), IL-8 (r= 0.349,
P= 0.095), or IL-6 (r= 0.211, P= 0.321). Post-run glycogen
levels were negatively related to muscle IL-6 protein content
(r= 0.55, P= 0.049), but not significantly to muscle IL-8
(r= 0.36, P= 0.120) or MCP-1 (r= 0.33, P= 0.160) pro-
tein content. Post-run glycogen levels were negatively related to
change in plasma IL-6 (r= 0.718, P< 0.001), IL-8 (r= 0.604,
P= 0.002), and MCP-1 (r= 0.589, P= 0.002) (Figure 4), but
not to change in serum cortisol (r= 0.011, P= 0.959) or plasma
epinephrine (r= 0.15, P= 0.478) (correlation figures not shown).
Changes in muscle and plasma IL-6 levels were significantly
FIGURE 1 | Pre-and post-exercise skeletal muscle glycogen levels in
N=24 runners.
FIGURE 2 | Fold change in skeletal muscle mRNA expression for IL-6,
IL-8, and MCP-1 in N= 24 runners. *P<0.001, change pre- to
post-exercise.
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A
B
FIGURE 3 | Skeletal muscle cytokine protein content for (A) IL-6 and
IL-8, and (B) MCP-1. *P0.005, change pre- to post-exercise.
TABLE 3 | Exercise effects on plasma cytokines and stress hormones.
Variable Pre-exercise Post-exercise
Plasma IL-6 (pgmL 1) 0.680.07 21.12.5*
Plasma IL-8 (pgmL 1) 4.240.24 14.91.0*
Plasma MCP-1 (pgmL 1) 1003.1 26413.7*
Serum cortisol (nmolL 1) 27211.0 51333.1*
Plasma epinephrine (pmolL 1) 39026.2 91266.6*
*P<0.001 versus pre-exercise.
IL, interleukin; MCP-1, monocyte chemoattractant protein-1.
related (r= 0.73, P< 0.001) (Figure 5), but not as strongly for
muscle and plasma IL-8 (r= 0.40,P= 0.080) orMCP-1 (r= 0.413,
P= 0.071) (correlation figures not shown). Changes in serum
cortisol and plasma epinephrine were not significantly related to
changes in muscle IL-6, IL-8, or MCP-1 mRNA or protein levels
(all, P> 0.05) (correlation figures not shown).
Discussion
As expected, these data from 24 male endurance athletes who
ran twice on treadmills to exhaustion at ~70% VO2max showed
increases in muscle IL-6, IL-8, and MCP-1 mRNA and protein
content, and corresponding increases in plasma levels for these
three cytokines. This study focused on the linkage betweenmuscle
glycogen availability and cytokine mRNA expression and pro-
duction, and showed that post-run muscle glycogen content was
A
B
C
FIGURE 4 | Correlations between post-exercise skeletal muscle
glycogen content and change in plasma (A) IL-6 (r= 0.718,
P< 0.001), (B) IL-8 (r= 0.604, P= 0.002), and (C) MCP-1
(r= 0.589, P= 0.002).
negatively related to plasma but not muscle mRNA levels for
IL-6, IL-8, and MCP-1. No significant correlations were found
between exercise-induced changes in stress hormones and plasma
or muscle cytokines (both mRNA and protein levels), similar to
results previously reported by our research group (10, 11).
The correlation between low muscle glycogen content and
enhanced muscle cytokine mRNA expression is not a consistent
finding, and depends on the study design, with the strongest
support demonstrated when participants initiate exercise with low
muscle glycogen levels (13, 26, 27). When participants engage in
prolonged, intensive exercise with normal pre-exercise glycogen
levels, depletion in muscle glycogen stores varies widely between
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FIGURE 5 | Correlation between exercise-induced changes in skeletal
muscle and plasma IL-6 levels (r=0.73, P< 0.001).
participants and typically cannot be linked to muscle IL-6 or IL-8
mRNA expression (10, 11, 14–16). Moreover, data from our lab-
oratory indicate that even though cycling induces greater vastus
lateralis muscle glycogen depletion in comparison to running,
muscle cytokine mRNA expression is multiple times greater with
running (10, 11). IL-6 release is markedly higher from the arm
compared with the leg during whole-body exercise, and is not
linked to muscle glycogen content (15). Additionally, carbohy-
drate compared to placebo ingestion during prolonged and inten-
sive exercise increases blood glucose levels and decreases muscle
mRNA expression and plasma levels for IL-6 and IL-8 despite
similar muscle glycogen depletion rates (10, 11). In the current
study, subjects drank water ad libitum during the mid-afternoon
running trials (3-h post-prandial state), without ingestion of any
other beverages or food. Thus carbohydrate ingestion would have
been expected to attenuate post-exercise increases in plasma IL-6
and IL-8, perhaps weakening the linkage to decreases in muscle
glycogen content. Although the data are not entirely consistent,
regular exercise bouts in the fasted state without oral carbohydrate
intake may enhance training adaptations (32, 33).
This is the first study to simultaneouslymeasuremuscle mRNA
expression, muscle protein content, and plasma levels for three
cytokines (IL-6, IL-8, and MCP-1) after exhaustive exercise.
Interpretation of the data from this study was strengthened by
combining results from two intense, long duration exercise ses-
sions for 24male runners (28), in contrast to other studies utilizing
small subject numbers and modest exercise workloads (14–17).
While others have shown increases in skeletal muscle MCP-1
mRNA following exercise (8), this study demonstrated that post-
exercise increases in both muscle MCP-1 mRNA expression and
protein content are unrelated to post-exercise muscle glycogen
levels. Della Gatta et al. (8) showed that muscle mRNA expression
and protein content for IL-6, IL-8, and MCP-1 were increased in
biopsy samples obtained from eight untrained men 2 h following
intensive leg resistance exercise. Plasma cytokine levels were not
reported in this study, but data suggested that MCP-1 and IL-8
were expressed by cells in the interstitial space between muscle
fibers, including macrophages, satellite cells, and other stromal
cells (8). A limitation in the current study is that repeated muscle
and blood sampleswere not collected during the first several hours
post-exercise that may have revealed additional insights.
Taken together, under the normal context withinwhich athletes
train and compete, muscle glycogen depletion at best represents
just one potential signal for cytokine mRNA expression within
muscle tissue. Other signaling mechanisms may include free fatty
acid availability, blood glucose levels, nitric oxide, and exercise-
induced muscle damage and adaptation (8, 11, 16, 20). Nonethe-
less, our data support a significant, modest, negative relation-
ship of post-exercise muscle glycogen and plasma cytokine levels
(13), and this could be due in part to the release of IL-6, IL-
8, and MCP-1 from extra-muscular sources, including adipose
tissue (3, 16) and the brain (7). Additionally, our data support
a significant, negative relationship between post-exercise muscle
glycogen content and both muscle and plasma IL-6 protein levels,
but not muscle IL-6 mRNA expression, suggesting that unmea-
sured factors within the secretome of the working skeletal muscle
may differentially influence cytokine mRNA stability, transcrip-
tion, production, degradation, modification, and release into the
circulation (12, 13).
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